PREDICTING MEDICINE DEMAND USING DEEP LEARNING TECHNIQUES
DOI:
https://doi.org/10.25195/ijci.v49i2.427Keywords:
RNN, LSTM, Bidirectional LSTM, GRU, Prediction medication needsAbstract
Medication supply and storage are essential components of the medical industry and distribution. Most medications have a predetermined expiration date. When the demand is met in large quantities that exceed the actual need, this leads to the accumulation of medicines in the stores, and this leads to the expiration of the materials. If demand is too low, this will have an impact on consumer happiness and drug marketing.
Therefore, it is necessary to find a way to predict the actual quantity required for the organization's needs to avoid material spoilage and storage problems. A mathematical prediction model is required to assist any management in achieving the required availability of medicines for customers and safe storage of medicines. The research question is to design a system based on deep learning that can predict the amount of drugs required with high efficiency and accuracy based on the chronology of previous years.Recurrent Neural Networks (RNN), Long Short-Term Memory (LSTM), Bidirectional LSTM, and Gated Recurrent Unit (GRU) are used to build prediction models. Those models allow for the optimization of inventory levels, thus reducing costs and potentially increasing sales. Various measures such as mean squared error (MSE), mean absolute squared error (MASE), root mean squared error (RMSE), and others are used to evaluate the prediction models. RNN model achieved the best result with MSE: 0.019 MAE: 0.102, RMSE: 0.0.
Downloads
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
IJCI applies the Creative Commons Attribution (CC BY) license to articles. The author of the submitted paper for publication by IJCI has the CC BY license. Under this Open Access license, the author gives an agreement to any author to reuse the article in whole or part for any purpose, even for commercial purposes. Anyone may copy, distribute, or reuse the content as long as the author and source are properly cited. This facility helps in re-use and ensures that journal content is available for the needs of research.
If the manuscript contains photos, images, figures, tables, audio files, videos, etc., that the author or the co-authors do not own, IJCI will require the author to provide the journal with proof that the owner of that content has given the author written permission to use it, and the owner has approved that the CC BY license being applied to content. IJCI provides a form that the author can use to ask for permission from the owner. If the author does not have owner permission, IJCI will ask the author to remove that content and/or replace it with other content that the author owns or has such permission to use.
Many authors assume that if they previously published a paper through another publisher, they have the right to reuse that content in their PLOS paper, but that is not necessarily the case – it depends on the license that covers the other paper. The author must ascertain the rights he/she has of a specific license (a license that enables the author to use the content). The author must obtain written permission from the publisher to use the content in the IJCI paper. The author should not include any content in her/his IJCI paper without having the right to use it, and always give proper attribution.
The accompanying submitted data should be stated with licensing policies, the policies should not be more restrictive than CC BY.
IJCI has the right to remove photos, captures, images, figures, tables, illustrations, audio, and video files, from a paper before or after publication, if these contents were included in the author's paper without permission from the owner of the content.
